Hypothyroidism associated with short bowel syndrome in children: a report of six cases

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Citação
ARCHIVES OF ENDOCRINOLOGY METABOLISM, v.62, n.6, p.655-660, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Short bowel syndrome (SBS) is the leading cause of intestinal failure in children, a condition of absence of sufficient bowel to meet the nutritional and metabolic needs of a growing individual. The treatment of patients in this situation is based on the association of parenteral and enteral nutrition for prolonged periods of time until intestinal rehabilitation occurs with complete enteral nutrition autonomy. Six consecutive cases of children with SBS (residual intestinal length of 5 cm to 75 cm) were managed with this program and were diagnosed with associated hypothyroidism during the treatment (ages at the diagnosis 5 months to 12 years). All patients were successfully treated with oral hormone reposition therapy and in one patient, the replacement was performed via rectal enemas due to a complete absence of small bowel. Although iodine deficiency associated to long-term parenteral nutrition is a well-known condition, this is the first report in the literature about an expressive number of patients with hypothyroidism detected in patients with SBS during the prolonged treatment for intestinal rehabilitation.
Palavras-chave
Referências
  1. Abrams SA, 2012, CLINICAL MANAGEMENT OF INTESTINAL FAILURE, P271
  2. Allan Philip, 2018, F1000Res, V7, P85, DOI 10.12688/f1000research.12493.1
  3. Araujo RL, 2008, J ENDOCRINOL, V198, P119, DOI 10.1677/JOE-08-0125
  4. Belfort MB, 2012, J CLIN ENDOCR METAB, V97, pE632, DOI 10.1210/jc.2011-3369
  5. Bello G, 2010, MINERVA ANESTESIOL, V76, P919
  6. Carbonnel F, 1996, JPEN-PARENTER ENTER, V20, P275, DOI 10.1177/0148607196020004275
  7. Chakrabarty I, 2012, CLINICAL MANAGEMENT OF INTESTINAL FAILURE, P13
  8. CHOPRA IJ, 1983, ANN INTERN MED, V98, P946, DOI 10.7326/0003-4819-98-6-946
  9. Cicalese MP, 2009, CLIN NUTR, V28, P256, DOI 10.1016/j.clnu.2009.02.005
  10. Clarridge KE, 2014, JPEN-PARENTER ENTER, V38, P901, DOI 10.1177/0148607113503370
  11. Cole CR, 2012, CLINICAL MANAGEMENT OF INTESTINAL FAILURE, P3
  12. COOPER A, 1984, J PEDIATR SURG, V19, P711, DOI 10.1016/S0022-3468(84)80357-7
  13. de Vries EM, 2015, J ENDOCRINOL, V224, P25, DOI 10.1530/JOE-14-0533
  14. Economidou F, 2011, HORM-INT J ENDOCRINO, V10, P117, DOI 10.14310/horm.2002.1301
  15. GALEA MH, 1992, J PEDIATR SURG, V27, P592, DOI 10.1016/0022-3468(92)90455-G
  16. Goulet O, 2004, J PEDIATR GASTR NUTR, V38, P250, DOI 10.1097/00005176-200403000-00006
  17. Hardy G, 2012, CLIN MANAGEMENT INTE
  18. Ibrahim M, 2003, ARCH DIS CHILD, V88, P56
  19. Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4
  20. Menezes HC-Filho, 2016, ENDOCRINOLOGIA PRATI, P267
  21. MOUKARZEL AA, 1992, J PEDIATR-US, V121, P252, DOI 10.1016/S0022-3476(05)81198-9
  22. Nicola JP, 2009, AM J PHYSIOL-CELL PH, V296, pC654, DOI 10.1152/ajpcell.00509.2008
  23. Pearson S, 2017, ENDOCRINOL DIABETES, V2017, P1
  24. Pinheiro CTC, 2015, LEVOTIROXINA RETAL T
  25. PURI P, 1982, J PEDIATR SURG, V17, P22, DOI 10.1016/S0022-3468(82)80319-9
  26. Salvia G, 2008, J PEDIATR, V153, P674, DOI 10.1016/j.jpeds.2008.05.017
  27. SHAMBAUGH GE, 1974, ENDOCRINOLOGY, V94, P1145, DOI 10.1210/endo-94-4-1145
  28. Tannuri U, 2016, REV ASSOC MED BRAS, V62, P575, DOI 10.1590/1806-9282.62.06.575
  29. Van den Berghe G, 2014, THYROID, V24, P1456, DOI 10.1089/thy.2014.0201
  30. vanHaasteren GAC, 1996, J ENDOCRINOL, V150, P169, DOI 10.1677/joe.0.1500169
  31. Wales PW, 2010, SEMIN PEDIATR SURG, V19, P3, DOI 10.1053/j.sempedsurg.2009.11.001
  32. Willard DL, 2017, ENDOCR PRACT, V23, P775, DOI 10.4158/EP161692.OR
  33. Yuksel O, 2009, J SURG RES, V155, P116, DOI 10.1016/j.jss.2008.07.036